Secondary Hypogonadism: How to Prep for Your First Visit

What Secondary Hypogonadism Actually Is

Secondary hypogonadism is a signaling problem, not a testicular problem. The testes themselves retain the capacity to produce testosterone and sperm, but the hypothalamus or pituitary gland is not sending the right instructions. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses; the pituitary responds by secreting luteinizing hormone (LH) and follicle-stimulating hormone (FSH); LH then drives testosterone production in Leydig cells, and FSH supports sperm maturation.

When that chain breaks down, testosterone falls. Yet LH and FSH stay low or inappropriately "normal" instead of rising in compensation. That low-LH-plus-low-testosterone fingerprint is what separates secondary hypogonadism from primary hypogonadism, where the testes themselves are damaged and LH/FSH surge in response.

Why the Distinction Matters Clinically

The Endocrine Society 2018 Clinical Practice Guideline on Male Hypogonadism states that clinicians "should distinguish between primary and secondary hypogonadism because the distinction affects treatment decisions, including fertility management." [1] Giving exogenous testosterone to a man with secondary hypogonadism shuts down his already-fragile GnRH-LH-FSH axis further, typically driving sperm counts to near zero within 3 months. [2] Fertility-preserving options like enclomiphene citrate or human chorionic gonadotropin (hCG) work precisely because the testes can still respond if stimulated appropriately.

Common Causes to Know Before Your Appointment

Causes split into congenital and acquired. Kallmann syndrome is the classic congenital form, combining GnRH deficiency with anosmia. Acquired causes are far more common in everyday clinical practice and include:

• Obesity. Adipose tissue converts testosterone to estradiol via aromatase, which suppresses GnRH. A 2014 study in the European Journal of Endocrinology found that 40 to 79 percent of severely obese men have low testosterone. [3]
• Opioid use. Chronic opioid therapy suppresses GnRH within days to weeks.
• Hyperprolactinemia. Elevated prolactin inhibits GnRH pulsatility; a prolactinoma is the most common pituitary tumor and must be ruled out.
• Sleep apnea. Testosterone peaks during REM sleep; untreated obstructive sleep apnea blunts that peak.
• Anabolic steroid use. Exogenous androgens suppress the hypothalamic-pituitary-gonadal (HPG) axis and may cause prolonged recovery. [4]

Knowing your likely cause before you arrive allows the clinician to spend time on treatment planning rather than history-taking.

The Lab Work You Should Have Before Your First Appointment

Getting the right tests done in advance saves a visit. Many telehealth and in-person hormone clinics will order labs for you before your consult, but if you are self-referring to an endocrinologist or urologist, having results ready shortens time to diagnosis.

Morning Testosterone Draw: The Non-Negotiable Starting Point

Total testosterone must be drawn between 7 AM and 10 AM. Testosterone follows a circadian rhythm, with peak concentrations in the morning. The Endocrine Society guideline recommends two separate fasting morning measurements before diagnosing hypogonadism, because a single low value has a 30 percent false-positive rate due to day-to-day variability. [1] A cutoff of <300 ng/dL (10.4 nmol/L) is the widely accepted threshold for a low result, though symptoms matter as much as the number.

The Full Hormone Panel

Bring results for all of the following if possible:

• Total testosterone (AM, fasting)
• Free testosterone (calculated or equilibrium dialysis method; important if SHBG is suspected to be high or low)
• LH and FSH (the values that confirm the "secondary" diagnosis)
• Prolactin (screens for prolactinoma)
• Estradiol (elevated in obesity, liver disease, or aromatase excess)
• SHBG (sex hormone-binding globulin; high SHBG lowers free testosterone even when total testosterone looks borderline)
• Thyroid-stimulating hormone (TSH) (hypothyroidism mimics low-T symptoms)
• CBC and comprehensive metabolic panel (baseline before any treatment)
• PSA (prostate-specific antigen; required before starting any testosterone therapy per FDA labeling) [5]

When to Ask for Additional Tests

Your clinician may add the following based on your history:

• MRI of the sella turcica if prolactin is >200 ng/mL, if you have headaches, or if you have visual field changes
• Karyotype or genetic testing if congenital hypogonadotropic hypogonadism is suspected
• Semen analysis if fertility is a concern, because sperm parameters can be preserved or recoverable even with low testosterone in secondary hypogonadism
• Hemoglobin A1c and fasting glucose given the bidirectional relationship between hypogonadism and type 2 diabetes [6]

What to Bring to the Appointment

Your Complete Medication List

Write down every prescription, over-the-counter drug, and supplement you take. Opioids, glucocorticoids, antipsychotics (which raise prolactin), antidepressants, ketoconazole, and anabolic steroids all affect the HPG axis. Your clinician cannot safely interpret your lab pattern without knowing this list. Bring doses and how long you have been taking each drug.

A Symptom Timeline

Secondary hypogonadism presents with a predictable cluster: reduced libido, erectile dysfunction, fatigue, depressed mood, decreased morning erections, reduced muscle mass, and increased body fat. [1] Write down when each symptom started and how severe it is on a 1-to-10 scale. Some clinics use validated tools like the Androgen Deficiency in Aging Males (ADAM) questionnaire or the International Index of Erectile Function (IIEF-5). Completing one before your visit signals clinical fluency and speeds history-taking.

Your Fertility Goals, Written Down

This single piece of information changes the entire treatment algorithm. Tell your clinician clearly:

• Are you currently trying to conceive?
• Do you want to preserve fertility for future use?
• Are you certain you do not want children?

If fertility matters to you, exogenous testosterone is generally contraindicated as first-line therapy. The American Urological Association (AUA) 2018 guidelines state that testosterone therapy is "relatively contraindicated in men who desire fertility in the near future." [7] Enclomiphene, clomiphene, hCG, or pulsatile GnRH are the options your clinician should be discussing instead.

Sleep Study Results or Sleep Apnea History

If you have been told you stop breathing at night, or if you snore heavily and wake unrefreshed, bring any prior polysomnography data. Treating obstructive sleep apnea with CPAP has been shown to raise testosterone by a mean of 72 ng/dL without any hormone therapy in one prospective study. [8] Treating the underlying cause before starting a hormone is always the preferred sequence.

Understanding Your Treatment Options Before You Walk In

You do not need to arrive knowing which treatment you want, but understanding the options at a basic level makes the conversation far more productive.

Exogenous Testosterone Therapy

Testosterone replacement therapy (TRT) corrects the testosterone deficiency directly. Available formulations include:

• Testosterone cypionate or enanthate (injectable, typically 100-200 mg every 1-2 weeks or weekly)
• Testosterone undecanoate (injectable, Aveed; 750 mg IM at 0, 4 weeks, then every 10 weeks)
• Transdermal gels or creams (AndroGel 1.62%, Testim, Natesto nasal gel)
• Pellet implants (Testopel; inserted subcutaneously every 3-6 months)

TRT reliably raises testosterone and improves symptoms. In the Testosterone Trials (TTrials, N=788 men aged 65 and older), testosterone gel improved sexual function, physical capacity, and bone density over 12 months. [9] The trade-off in secondary hypogonadism specifically is HPG axis suppression. Exogenous testosterone signals the hypothalamus to stop producing GnRH, which stops LH/FSH, which stops sperm production. Recovery after stopping TRT is not guaranteed and may take 6 to 24 months or longer. [2]

Enclomiphene Citrate

Enclomiphene is the trans-isomer of clomiphene. It blocks estrogen receptors in the hypothalamus, removing the negative feedback that is suppressing GnRH, which then restores the LH-FSH-testosterone cascade from within the body. Because it works upstream, it preserves the HPG axis and sperm production.

A randomized controlled trial published in Fertility and Sterility (N=90) comparing enclomiphene to testosterone gel found that enclomiphene maintained sperm concentrations above 15 million/mL in 92 percent of men at 3 months, while testosterone gel reduced concentrations below 15 million/mL in 94 percent of men in the same period. [10] Typical dosing is 12.5 to 25 mg orally once daily. It is not FDA-approved for male hypogonadism as a stand-alone indication, but it is widely used off-label and has strong mechanistic rationale for secondary hypogonadism specifically.

Human Chorionic Gonadotropin (hCG)

HCG mimics LH at the Leydig cell level, stimulating intratesticular testosterone production without suppressing the pituitary. It is particularly useful when the problem is pituitary-level LH deficiency. Dosing typically runs 1,500 to 5,000 IU subcutaneously 2 to 3 times per week.

In a study by Wenker et al. Published in the Journal of Urology (N=26), men with secondary hypogonadism treated with hCG monotherapy showed a mean testosterone increase from 208 ng/dL to 498 ng/dL over 6 months, with preserved semen parameters. [11] hCG is often combined with FSH (human menopausal gonadotropin or recombinant FSH) in men who also need to improve sperm production, particularly in Kallmann syndrome.

Lifestyle Modification as First-Line for Reversible Causes

Before any prescription is written, reversible contributing factors deserve direct attention. Weight loss of 10 percent body weight in obese men has been associated with testosterone increases of 60 to 100 ng/dL. [3] Stopping opioids, treating sleep apnea, and managing stress may normalize the axis entirely, making pharmacotherapy unnecessary. Your clinician should walk through these options explicitly at the first visit.

Questions to Ask Your Clinician

Arriving with prepared questions transforms a passive appointment into a productive clinical conversation. Use this list as a starting point.

Questions About Diagnosis

• "My LH and FSH are [value]. Does that confirm the secondary pattern, or do I need additional testing?"
• "Should I get an MRI of my pituitary given my prolactin level?"
• "Could any of my current medications be causing this?"

Questions About Treatment

• "Given my fertility goals, is testosterone therapy appropriate for me right now?"
• "Would enclomiphene or hCG be a better first step while I preserve fertility options?"
• "How long before I expect symptom improvement on whichever treatment we choose?"
• "What do my labs need to show before we consider a dose adjustment?"

Questions About Monitoring

• "How often will you check my testosterone, LH, FSH, CBC, and PSA after starting treatment?"
• "What estradiol level are you targeting, and will you prescribe an aromatase inhibitor if it goes too high?"
• "If I want to stop treatment and try to conceive, what is the recovery protocol?"

What Happens After the First Visit

The first appointment ends with a working diagnosis and a treatment plan, but the real management is in what follows.

Monitoring Schedule After Starting Treatment

The Endocrine Society recommends checking testosterone, hematocrit, and PSA at 3 to 6 months after treatment initiation and annually thereafter. [1] For men on injectable testosterone, timing the draw matters: a mid-cycle trough or a mid-cycle peak reading gives very different numbers. Ask specifically when your lab should be drawn relative to your injection day.

Recognizing Side Effects Early

Common side effects by treatment class:

• TRT: erythrocytosis (hematocrit >54%), acne, testicular atrophy, suppressed fertility, possible exacerbation of sleep apnea, and a small risk of polycythemia requiring phlebotomy
• Enclomiphene / clomiphene: mood changes, visual disturbances (rare but require immediate evaluation), and elevated estradiol
• hCG: injection-site reactions, elevated estradiol, and rare risk of gynecomastia if estradiol is not monitored

Erythrocytosis is the most clinically significant TRT complication. The FDA-approved labeling for testosterone products requires that hematocrit be checked before initiation and during treatment. [5] A hematocrit above 54 percent is an indication to hold or reduce the dose.

When Referral to Reproductive Endocrinology Is Appropriate

If your primary goal is fertility and testosterone is very low (<150 ng/dL) or you have not responded to enclomiphene at 3 months, a referral to a reproductive endocrinologist or andrologist is appropriate. Combination hCG plus FSH therapy for fertility induction in hypogonadotropic hypogonadism has pregnancy success rates of 50 to 90 percent depending on the duration of hypogonadism and prior testicular development. [12]

Red Flags That Need Same-Day or Urgent Evaluation

Most secondary hypogonadism is a slow, chronic process. A few presentations require faster action.

• Prolactin >200 ng/mL with or without galactorrhea or visual field changes suggests a macroprolactinoma and needs urgent pituitary MRI and endocrinology referral.
• Sudden severe headache with visual loss in a man known to have a pituitary adenoma suggests pituitary apoplexy, which is a neurosurgical emergency.
• New-onset secondary hypogonadism after head trauma may indicate traumatic hypopituitarism; up to 25 percent of moderate-to-severe traumatic brain injury patients develop some degree of hypopituitarism. [13]

A low testosterone reading alone does not require the ER. But the context around it does matter. Share your full symptom history, not just the lab number.